ArticleBMJ case reports2023

PD-1 Inhibition in metastatic high tumour mutational burden (TMB) leiomyosarcoma with clinicopathological correlates.

Divita Pandita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.